| Human mesenchymal stem cells modulate B-cell functions A Corcione, F Benvenuto, E Ferretti, D Giunti, V Cappiello, F Cazzanti, ... Blood 107 (1), 367-372, 2006 | 2441 | 2006 |
| BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism C Durante, E Puxeddu, E Ferretti, R Morisi, S Moretti, R Bruno, F Barbi, ... The Journal of Clinical Endocrinology & Metabolism 92 (7), 2840-2843, 2007 | 453 | 2007 |
| Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse F Calcinaro, S Dionisi, M Marinaro, P Candeloro, V Bonato, S Marzotti, ... Diabetologia 48, 1565-1575, 2005 | 451 | 2005 |
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis A Corcione, S Casazza, E Ferretti, D Giunti, E Zappia, A Pistorio, ... Proceedings of the National Academy of Sciences 101 (30), 11064-11069, 2004 | 420 | 2004 |
| Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses A Naji, C Menier, F Morandi, S Agaugué, G Maki, E Ferretti, S Bruel, ... The journal of immunology 192 (4), 1536-1546, 2014 | 189 | 2014 |
| Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal L Di Marcotullio, A Greco, D Mazzà, G Canettieri, L Pietrosanti, P Infante, ... Oncogene 30 (1), 65-76, 2011 | 136 | 2011 |
| Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies E Ferretti, V Pistoia, A Corcione Mediators of inflammation 2014, 2014 | 100 | 2014 |
| Harnessing NK cells for cancer treatment P Minetto, F Guolo, S Pesce, M Greppi, V Obino, E Ferretti, S Sivori, ... Frontiers in immunology 10, 2836, 2019 | 84 | 2019 |
| Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells F Morandi, E Ferretti, R Castriconi, A Dondero, A Petretto, C Bottino, ... Blood, The Journal of the American Society of Hematology 118 (22), 5840-5850, 2011 | 84 | 2011 |
| Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors E Ferretti, E Tosi, A Po, A Scipioni, R Morisi, MS Espinola, D Russo, ... The Journal of Clinical Endocrinology & Metabolism 93 (10), 4080-4087, 2008 | 81 | 2008 |
| CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells A Corcione, N Arduino, E Ferretti, L Raffaghello, S Roncella, D Rossi, ... Clinical cancer research 10 (3), 964-971, 2004 | 70 | 2004 |
| Canonical and non-canonical adenosinergic pathways E Ferretti, AL Horenstein, C Canzonetta, F Costa, F Morandi Immunology letters 205, 25-30, 2019 | 67 | 2019 |
| A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis F Morandi, E Ferretti, P Bocca, I Prigione, L Raffaghello, V Pistoia PLoS One 5 (7), e11763, 2010 | 67 | 2010 |
| The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment E Ferretti, A Corcione, V Pistoia Journal of leukocyte biology 102 (3), 711-717, 2017 | 66 | 2017 |
| Hurthle cell tumours of the thyroid. Personal experience and review of the literature A Barnabei, E Ferretti, R Baldelli, A Procaccini, G Spriano, M Appetecchia Acta Otorhinolaryngologica Italica 29 (6), 305, 2009 | 63 | 2009 |
| Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg−/− Mice A Zorzoli, E Di Carlo, C Cocco, E Ognio, D Ribatti, E Ferretti, C Dufour, ... Clinical cancer research 18 (6), 1630-1640, 2012 | 58 | 2012 |
| Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas S Ulisse, E Baldini, M Toller, E Marchioni, L Giacomelli, E De Antoni, ... European Journal of Cancer 42 (15), 2631-2638, 2006 | 55 | 2006 |
| The endocrine disruptor cadmium: a new player in the pathophysiology of metabolic diseases VM Bimonte, ZM Besharat, A Antonioni, V Cella, A Lenzi, E Ferretti, ... Journal of endocrinological investigation 44, 1363-1377, 2021 | 54 | 2021 |
| A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment E Ferretti, M Bertolotto, S Deaglio, C Tripodo, D Ribatti, V Audrito, ... Leukemia 25 (8), 1268-1277, 2011 | 54 | 2011 |
| Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets E Ferretti, L Di Marcotullio, M Gessi, T Mattei, A Greco, A Po, E De Smaele, ... Oncogene 25 (55), 7267-7273, 2006 | 53 | 2006 |
